The projections in Digital Therapeutics Market report are made by analyzing the current trends & future market potential from 2020 to 2027, in terms of value.

NE WIN SIVERS DRIVE, PORTLAND, UNITED STATES, September 7, 2021 /EINPresswire.com/ -- The Digital Therapeutics Market was pegged at $2.88 billion in 2019, and is projected to reach $13.80 billion by 2027, growing at a CAGR of 20.5% from 2020 to 2027. Digital therapeutics Provide evidence-based treatment with software that replaces or complements existing treatment for a disease. Moreover, during this pandemic, people are required to stay at home, which leads to less physical activity, unhealthy lifestyle, mental stress, and prevalence of chronic diseases and rapid technological advancements. Hence, there is a rise in demand of digital therapeutics (DTx) devices and software across the country.

Increase in implementation of smartphones and tablets along with healthcare apps, surge in incidences of chronic diseases, and growth in need to control healthcare costs propel the growth of the global digital therapeutics market. On the other hand, lack of awareness regarding digital therapeutics in emerging economies and concerns regarding data privacy restrain the growth to certain extent. Conversely, emerging markets across developing countries are anticipated to usher a number of opportunities in the future.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2117

Covid-19 scenario:
? The Food and Drug Administration (FDA) guidelines of April 2020 state that this will allow the distribution and use of digital devices to treat mental health disorders during a pandemic.
? As a result, suppliers and consumers are turning to digital therapies more and more. The COVID-19 epidemic is expected to positively impact the development of the global digital therapeutics (DTx) market.

The global market is segmented on the basis of application, product type, sales channel, and region. Based on application, the diabetes segment dominated the market in 2019, accounting for nearly one-fourth of the global market. In addition, the segment is anticipated to maintain its dominance throughout the forecast period. However, the obesity segment is expected to manifest the highest CAGR of 23.2% during the forecast period. The report also involves segments including cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others.

Based on sales channel, the market is bifurcated into business to consumers and business to business. The business to consumers segment accounted for the largest share in 2019, contributing to nearly three-fifths of the total market share. At the same time, the segment is estimated to register the highest CAGR of 21.3% in between 2019 to 2027.

Based on region, the global market across North America held the lion?s share in 2019, accounting for nearly half of the total revenue. The region, furthermore, is anticipated to dominate the market throughout the forecast period. On contrary, the global digital therapeutics market across Asia-Pacific is projected to manifest the highest CAGR of 22.2% during the forecast period.

Major market players in the report involves

? 2MORROW, Inc.,
? Akili Interactive Labs, Inc.
? Click Therapeutics, Inc.
? Fitbit, Inc. (Twine Health, Inc.)
? Happify, Inc.
? Kaia Health
? Livongo Health, Inc.
? Medtronic Plc.
? Omada Health, Inc.
? Pear Therapeutics, Inc.
? Proteus Digital Health, Inc.
? Resmed, Inc. (Propeller Health)
? Voluntis, Inc.
? Welldoc, Inc.

The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn